TC BioPharm, Medinet to develop new cancer therapies - 1 views
-
Alex Parker on 13 Mar 14Scottish biotechnology firm TC BioPharm (TCB) and Japanese immuno-cell therapy company Medinet have entered into a strategic collaboration to develop a new treatment for different types of cancer.